Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease
<p>Hypovitaminosis D is highly prevalent in chronic kidney disease (CKD). Recently, vitamin D has sparked widespread interest because of its potential favorable benefits on cardiovascular disease (CVD). Evidence from clinical studies and animal models supports the existence of biphasic cardiov...
Main Author: | Peng Hu, Qiang Xuan, Bo Hu, Ling Lu, Jing Wang, Yuan Han Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2012-01-01
|
Series: | International Journal of Biological Sciences |
Online Access: | http://www.biolsci.org/v08p0663.htm |
Similar Items
-
Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease
by: Kosaku Nitta
Published: (2018-08-01) -
The Biphasic Effect of Vitamin D on the Musculoskeletal and Cardiovascular System
by: Armin Zittermann
Published: (2017-01-01) -
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
by: F U Dzgoeva, et al.
Published: (2014-06-01) -
Fibroblast growth factor-23 in canine chronic kidney disease
by: Harjes, Laura
Published: (2017) -
Role of fibroblast growth factor 23 in patients with chronic kidney disease
by: Song-Yan Wang, et al.
Published: (2021-02-01)